Molecules (Basel, Switzerland) · 2026
Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut-Liver In Vitro Model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mulè Simone, Galla Rebecca, Musu Matteo, Parini Francesca, Molinari Claudio, Uberti Francesca
Аннотация
Dysregulated hepatic cholesterol handling and oxidative stress represent key targets for nutritional interventions. This study investigated a combination of Ophiocordyceps sinensis (formerly Cordyceps sinensis) extract and coenzyme Q10 (CoQ10) using a sequential gut-liver in vitro model. Differentiated Caco-2/HT29-MTX co-cultures were used to assess intestinal transport, transepithelial electrical resistance (TEER), and junctional organisation. The resulting basolateral intestinal-conditioned medium was applied to high-glucose-stressed HepG2 cells. The combined treatment-maintained epithelial electrical integrity (TEER > 400 Ω·cm2) and tight junction protein abundance, while transiently increasing paracellular fluorescein transport (Papp) and enhancing basolateral CoQ10 recovery (+29%). In HepG2 cells, the conditioned medium reduced superoxide production (-38%) and enhanced both DiI-labelled low-density lipoprotein (DiI-LDL) uptake (+26%) and intracellular total bile acid content (+33%). These functional outcomes were accompanied by coordinated changes in protein abundance: a decrease in sterol regulatory element-binding protein 2 (SREBP-2), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels, alongside increased low-density lipoprotein receptor (LDLR), cytochrome P450 family 7 subfamily A member 1 (CYP7A1), and ATP-binding cassette transporter A1 (ABCA1) expression. Pharmacological inhibition with dorsomorphin suggested a partial involvement of AMP-activated protein kinase (AMPK) signalling, although this mechanistic assessment remained exploratory. Overall, these findings demonstrate the coordinated modulation of intestinal transport, functional hepatic endpoints, and cholesterol-related protein abundance.